Cerebellar tDCS in Children With Autism Spectrum Disorder

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Autism Spectrum Disorder

In brief

The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.

Key facts

Study ID

NCT04446442

Run by

University of Texas Southwestern Medical Center

People needed

60

Starts

2019-06-04

Expected to finish

2027-12-31

Last updated by the study team

2026-06-04

Who can join

Age: 4 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 4-17 years old
• Diagnosed with ASD and ADOS-2
• IQ Score no less than 70 (1.5 Standard Deviations below the mean)
• Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences)

You may not qualify if…

• Brain implants, metal implants, pacemakers, or biomedical devices
• Diagnosis of epilepsy
• Hearing or visual impairments
• History of brain injury
• Known brain abnormalities not associated with ASD

Where it is running

• Children's Medical Center — Dallas, Texas, United States (enrolling)
• University of Texas Southwestern — Dallas, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.